Lessons from rare diseases of cartilage and bone

Current Opinion in Pharmacology

Volumn 22, Issue , 2015, Pages 107-114

  Gallagher, James A ^a   Ranganath, Lakshminarayan R ^a,b   Boyde, Alan ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CATHEPSIN K; GROWTH DIFFERENTIATION FACTOR 5; LUBRICIN; MEMBRANE PROTEIN; SCLEROSTIN; UNCLASSIFIED DRUG; BONE DENSITY CONSERVATION AGENT;

ALKAPTONURIA; ARTHROPATHY; ARTICLE; BONE DISEASE; BONE TURNOVER; CHONDROCALCINOSIS; CHONDRODYSPLASIA; CHONDROPATHY; DISEASE ASSOCIATION; DRUG INDICATION; DRUG TARGETING; HUMAN; MOLECULAR GENETICS; OSSIFICATION; OSTEOARTHRITIS; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; RARE DISEASE; REGULATORY MECHANISM; ANIMAL; BONE DISEASES; CARTILAGE DISEASES; DRUG DESIGN; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; RARE DISEASES;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES; CARTILAGE DISEASES; DIPHOSPHONATES; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY; OSTEOARTHRITIS; PHENOTYPE; RARE DISEASES;

EID: 84930821074     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.04.002     Document Type: Review

References (70)

1. W. Bateson The Methods and Scope of Genetics. Inaugural Lecture Delivered 23 Oct 1908 1908 Cambridge University Press
2. W. Harvey Letter IX, to John Vlackveld 1657
3. A. Vogt The genetics of familial hypercholesterolemia and emerging therapies Appl Clin Genet 8 2015 27 36
4. T.M. Cox Alkaptonuria: leading to the treasure in exceptions JIMD Rep 5 2012 49 57
5. M.P. Whyte Physiological role of alkaline phosphatase explored in hypophosphatasia Ann N Y Acad Sci 1192 2010 190 220
6. R.G. Russell Excretion of inorganic pyrophosphate in hypophosphatasia Lancet 2 1965 461 464
7. H. Fleisch, J. Maerki, and R.G. Russell Effect of pyrophosphate on dissolution of hydroxyapatite and its possible importance in calcium homeostasis Proc Soc Exp Biol Med 122 1966 317 320
8. R.G. Russell Bisphosphonates: the first 40 years Bone 49 2011 2 19
9. J.D. Hald, E. Evangelou, B.L. Langdahl, and S.H. Ralston Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials J Bone Miner Res 30 2015 929 933
10. M.A. Karsdal, A.C. Bay-Jensen, R.J. Lories, S. Abramson, T. Spector, P. Pastoureau, C. Christiansen, M. Attur, K. Henriksen, S.R. Goldring, and V. Kraus The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? Ann Rheum Dis 73 2014 336 348
11. K. Tezuka, Y. Tezuka, A. Maejima, T. Sato, K. Nemoto, H. Kamioka, Y. Hakeda, and M. Kumegawa Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts J Biol Chem 269 1994 1106 1109
12. T. Inaoka, G. Bilbe, O. Ishibashi, K. Tezuka, M. Kumegawa, and T. Kokubo Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone Biochem Biophys Res Commun 206 1995 89 96
13. B.D. Gelb, G.P. Shi, H.A. Chapman, and R.J. Desnick Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency Science 273 1996 1236 1238
14. A. Littlewood-Evans, T. Kokubo, O. Ishibashi, T. Inaoka, B. Wlodarski, J.A. Gallagher, and G. Bilbe Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry Bone 20 1997 81 86
15. A.J. Littlewood-Evans, G. Bilbe, W.B. Bowler, D. Farley, B. Wlodarski, T. Kokubo, T. Inaoka, J. Sloane, D.B. Evans, and J.A. Gallagher The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma Cancer Res 57 1997 5386 5390
16. H.G. Bone, D.W. Dempster, J.A. Eisman, S.L. Greenspan, M.R. McClung, T. Nakamura, S. Papapoulos, W.J. Shih, A. Rybak-Feiglin, A.C. Santora, N. Verbruggen, A.T. Leung, and A. Lombardi Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-term Odanacatib Fracture Trial Osteoporos Int 26 2015 699 712
17. T.J. Chambers, and J.H. Tobias Are cathepsin k inhibitors just another class of anti-resorptives? J Clin Endocrinol Metab 98 2013 4329 4331
18. W. Balemans, M. Ebeling, N. Patel, E. Van Hul, P. Olson, M. Dioszegi, C. Lacza, W. Wuyts, J. Van Den Ende, P. Willems, A.F. Paes-Alves, S. Hill, M. Bueno, F.J. Ramos, P. Tacconi, F.G. Dikkers, C. Stratakis, K. Lindpaintner, B. Vickery, D. Foernzler, and W. Van Hul Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) Hum Mol Genet 10 2001 537 543
19. W. Balemans, N. Patel, M. Ebeling, E. Van Hul, W. Wuyts, C. Lacza, M. Dioszegi, F.G. Dikkers, P. Hildering, and P.J. Willems Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease J Med Genet 39 2002 91 97
20. G.G. Loots, M. Kneissel, H. Keller, M. Baptist, J. Chang, N.M. Collette, D. Ovcharenko, I. Plajzer-Frick, and E.M. Rubin Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease Genome Res 15 2005 928 935
21. K.E. Poole, R.L. van Bezooijen, N. Loveridge, H. Hamersma, S.E. Papapoulos, C.W. Lowik, and J. Reeve Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation FASEB J 19 2005 1842 1844
22. H. Keller, and M. Kneissel SOST is a target gene for PTH in bone Bone 37 2005 148 158
23. D. Padhi, G. Jang, B. Stouch, L. Fang, and E. Posvar Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody J Bone Miner Res 26 2011 19 26
24. J. McColm, L. Hu, T. Womack, C.C. Tang, and A.Y. Chiang Single- and multiple-dose randomized studies of blosozumab, a monoclonal antibody against sclerostin, in healthy postmenopausal women J Bone Miner Res 29 2013 935 943
25. M.R. McClung, A. Grauer, S. Boonen, M.A. Bolognese, J.P. Brown, A. Diez-Perez, B.L. Langdahl, J.Y. Reginster, J.R. Zanchetta, and S.M. Wasserman Romosozumab in postmenopausal women with low bone mineral density N Engl J Med 370 2014 412 420
26. M. Semenov, K. Tamai, and X. He SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor J Biol Chem 280 2005 26770 26775
27. X. Li, Y. Zhang, H. Kang, W. Liu, P. Liu, J. Zhang, S.E. Harris, and D. Wu Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling J Biol Chem 280 2005 19883 19887
28. W. Balemans, E. Piters, E. Cleiren, M. Ai, L. Van Wesenbeeck, M.L. Warman, and W. Van Hul The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations Calcif Tissue Int 82 2008 445 455
29. B.Y. Chan, E.S. Fuller, A.K. Russell, S.M. Smith, M.M. Smith, M.T. Jackson, M.A. Cake, R.A. Read, J.F. Bateman, P.N. Sambrook, and C.B. Little Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis Osteoarthritis Cartilage 19 2011 874 885
30. W. Bouaziz, T. Funck-Brentano, H. Lin, C. Marty, H.K. Ea, E. Hay, and M. Cohen-Solal Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways Arthritis Res Ther 17 2015 24 (Epub ahead of print)
31. M. Roudier, X. Li, Q.T. Niu, E. Pacheco, J.K. Pretorius, K. Graham, B.R. Yoon, J. Gong, K. Warmington, H.Z. Ke, R.A. Black, J. Hulme, and P. Babij Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury Arthritis Rheum 65 2013 721 731
32. J.Y. Yan, F.M. Tian, W.Y. Wang, Y. Cheng, H.P. Song, Y.Z. Zhang, and L. Zhang Parathyroid hormone (1-34) prevents cartilage degradation and preserves subchondral bone micro-architecture in guinea pigs with spontaneous osteoarthritis Osteoarthritis Cartilage 22 2014 1869 1877
33. P. Kannu, J.F. Bateman, D. Belluoccio, A.J. Fosang, and R. Savarirayan Employing molecular genetics of chondrodysplasias to inform the study of osteoarthritis Arthritis Rheum 60 2009 325 334
34. E.E. Storm, T.V. Huynh, N.G. Copeland, N.A. Jenkins, D.M. Kingsley, and S.J. Lee Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily Nature 368 1994 639 643
35. L.M. Graul-Neumann, A. Deichsel, U. Wille, N. Kakar, R. Koll, C. Bassir, J. Ahmad, V. Cormier-Daire, S. Mundlos, C. Kubisch, G. Borck, E. Klopocki, T.D. Mueller, S.C. Doelken, and P. Seemann Homozygous missense and nonsense mutations in BMPR1B cause acromesomelic chondrodysplasia-type Grebe Eur J Hum Genet 22 2014 726 733
36. J.T. Thomas, K. Lin, M. Nandedkar, M. Camargo, J. Cervenka, and F.P. Luyten A human chondrodysplasia due to a mutation in a TGF-beta superfamily member Nat Genet 12 1996 315
37. M. Ratnayake, F. Plöger, M. Santibanez-Koref, and J. Loughlin Human chondrocytes respond discordantly to the protein encoded by the osteoarthritis susceptibility gene GDF5 PLoS One 9 2014 e86590
38. E. Evangelou, K. Chapman, I. Meulenbelt, F.B. Karassa, J. Loughlin, A. Carr, M. Doherty, S. Doherty, J.J. Gómez-Reino, and A. Gonzalez Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand Arthritis Rheum 60 2009 1710 1721
39. L.N. Reynard, and J. Loughlin The genetics and functional analysis of primary osteoarthritis susceptibility Expert Rev Mol Med 15 2013 e2
40. L.H.W. Kung, M.H. Rajpar, R. Preziosi, M.D. Briggs, and R.P. Boot-Handford Increased classical endoplasmic reticulum stress is sufficient to reduce chondrocyte proliferation rate in the growthplate and decrease bone growth PLoS One 10 2015 e0117016
41. T.L. Cameron, I.L. Gresshoff, K.M. Bell, K.A. Piróg, L. Sampurno, C.L. Hartley, E.M. Sanford, R. Wilson, J. Ermann, R.P. Boot-Handford, L.H. Glimcher, M.D. Briggs, and J.F. Bateman Cartilage-specific ablation of XBP1 signaling in mouse results in a chondrodysplasia characterized by reduced chondrocyte proliferation and delayed cartilage maturation and mineralization Osteoarthritis Cartilage 23 2015 661 670
42. J. Marcelino, J.D. Carpten, W.M. Suwairi, O.M. Gutierrez, S. Schwartz, C. Robbins, R. Sood, I. Makalowska, A. Baxevanis, B. Johnstone, R.M. Laxer, L. Zemel, C.A. Kim, J.K. Herd, J. Ihle, C. Williams, M. Johnson, V. Raman, L.G. Alonso, D. Brunoni, A. Gerstein, N. Papadopoulos, S.A. Bahabri, J.M. Trent, and M.L. Warman CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome Nat Genet 23 1999 319 322
43. D.K.1. Rhee, J. Marcelino, S. Al-Mayouf, D.K. Schelling, C.F. Bartels, Y. Cui, R. Laxer, R. Goldbach-Mansky, and M.L. Warman Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing J Biol Chem 280 2005 31325 31332
44. M. Ai, Y. Cui, M.S. Sy, D.M. Lee, L.X. Zhang, K.M. Larson, K.C. Kurek, G.D. Jay, and M.L. Warman Anti-lubricin monoclonal antibodies created using lubricin-knockout mice immunodetect lubricin in several species and in patients with healthy and diseased joints PLoS One 10 2015 e0116237
45. M.Z. Ruan, A. Erez, K. Guse, B. Dawson, T. Bertin, Y. Chen, M.M. Jiang, J. Yustein, F. Gannon, and B.H. Lee Proteoglycan 4 expression protects against the development of osteoarthritis Sci Transl Med 5 2013 176ra134
46. H.O. Sweet, and M.C. Green Progressive ankylosis, a new skeletal mutation in the mouse J Hered 72 1981 87 931
47. A. Abhishek, and M. Doherty Pathophysiology of articular chondrocalcinosis - role of ANKH Nat Rev Rheumatol 7 2011 96 104
48. J. Bertrand, Y. Nitschke, M. Fuerst, S. Hermann, M. Schäfers, J. Sherwood, G. Nalesso, W. Ruether, F. Rutsch, F. Dell'Accio, and T. Pap Decreased levels of nucleotide pyrophosphatase phosphodiesterase 1 are associated with cartilage calcification in osteoarthritis and trigger osteoarthritic changes in mice Ann Rheum Dis 71 2012 1249 1253
49. A.K. Rosenthal, C.M. Gohr, E. Mitton-Fitzgerald, M.K. Lutz, G.R. Dubyak, and L.M. Ryan The progressive ankylosis gene product ANK regulates extracellular ATP levels in primary articular chondrocytes Arthritis Res Ther 15 2013 R154
50. X. Guo, W.J. Ma, F. Zhang, F.L. Ren, C.J. Qu, and M.J. Lammi Recent advances in the research of an endemic osteochondropathy in China: Kashin-Beck disease Osteoarthritis Cartilage 22 2014 1774 1778
51. J.A. Gallagher, L.R. Ranganath, and A. Zatkova Alkaptonuria edn 2 S. Maloy, K. Hughes, Brenner's Encyclopedia of Genetics vol 1 2013 Academic Press San Diego 71 75
52. A.E. Garrod Inborn Errors of Metabolism; The Croonian Lectures Delivered Before the Royal College of Physicians of London, in June. Henry Frowde, Hodder and Stoughton 1908 Oxford University Press London
53. T.R. Helliwell, J.A. Gallagher, and L. Ranganath Alkaptonuria - a review of surgical and autopsy pathology Histopathology 53 2008 503 512
54. L. Tinti, A.M. Taylor, A. Santucci, B. Wlodarski, P.J. Wilson, J.C. Jarvis, W.D. Fraser, J.S. Davidson, L.R. Ranganath, and J.A. Gallagher Development of an in vitro model to investigate joint ochronosis in alkaptonuria Rheumatology (Oxford) 50 2011 271 277
55. A.M. Taylor, B. Wlodarski, I.A. Prior, P.J. Wilson, J.C. Jarvis, L.R. Ranganath, and J.A. Gallagher Ultrastructural examination of tissue in a patient with alkaptonuric arthropathy reveals a distinct pattern of binding of ochronotic pigment Rheumatology 49 2010 1412 1414
56. A.M. Taylor, A. Boyde, P.J. Wilson, J.C. Jarvis, J.S. Davidson, J.A. Hunt, L.R. Ranganath, and J.A. Gallagher The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria Arthritis Rheum 63 2011 3887 3896
57. A.M. Taylor, A.J. Preston, N.K. Paulk, H. Sutherland, C.M. Keenan, P.J. Wilson, B. Wlodarski, M. Grompe, L.R. Ranganath, J.A. Gallagher, and J.C. Jarvis Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition Osteoarthritis Cartilage 20 2012 880 886
58. A.J. Preston, C.M. Keenan, H. Sutherland, P.J. Wilson, B. Wlodarski, A.M. Taylor, D.P. Williams, L.R. Ranganath, J.A. Gallagher, and J.C. Jarvis Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and itsinhibition by nitisinone Ann Rheum Dis 73 2014 284 289
59. N. Verzijl, J. DeGroot, Z.C. Ben, O. Brau-Benjamin, A. Maroudas, R.A. Bank, J. Mizrahi, C.G. Schalkwijk, S.R. Thorpe, J.W. Baynes, J.W. Bijlsma, F.P. Lafeber, and J.M. TeKoppele Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis Arthritis Rheum 46 2002 114 123
60. F. Berenbaum Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype Ann Rheum Dis 70 2011 1354 1356 10.1136/ard.2010.146399
61. J. Hirose, S. Yamabe, K. Takada, N. Okamoto, R. Nagai, and H. Mizuta Immunohistochemical distribution of advanced glycation end products (AGEs) in human osteoarthritic cartilage Acta Histochem 113 2011 613 618
62. A. Boyde, G.R. Davis, D. Mills, T. Zikmund, T.M. Cox, V.L. Adams, A. Niker, P.J. Wilson, J.P. Dillon, L.R. Ranganath, N. Jeffery, J.C. Jarvis, and J.A. Gallagher On fragmenting, densely mineralised acellular protrusions into articular cartilage and their possible role in osteoarthritis J Anat 225 2014 436 446
63. S. Mori, R. Harruff, and D.B. Burr Microcracks in articular calcified cartilage of human femoral heads Arch Pathol Lab Med 117 1993 196 198
64. L. Sokoloff Microcracks in the calcified layer of articularcartilage Arch Pathol Lab Med 117 1993 191 195
65. A. Boyde The real response of bone to exercise J Anat 203 2003 173 189
66. A. Boyde, C.M. Riggs, A.J. Bushby, B. McDermott, G.L. Pinchbeck, and P.D. Clegg Cartilage damage involving extrusion of mineralisable matrix from the articular calcified cartilage and subchondral bone Eur Cell Mater 21 2011 470 478
67. A.M. Taylor, A. Boyde, J.S. Davidson, J.C. Jarvis, L.R. Ranganath, and J.A. Gallagher Identification of trabecular excrescences, novel microanatomical structures, present in bone in osteoarthropathies Eur Cell Mater 23 2012 300 308
68. D.A. Walsh, and V. Chapman Bisphosphonates for osteoarthritis Arthritis Res Ther 13 2011 128
69. J.Y. Reginster, J. Badurski, N. Bellamy, W. Bensen, R. Chapurlat, X. Chevalier, C. Christiansen, H. Genant, F. Navarro, E. Nasonov, P.N. Sambrook, T.D. Spector, and C. Cooper Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial Ann Rheum Dis 72 2013 179 186
70. A. Boyde Staining plastic blocks with triiodide to image cells and soft tissues in backscattered electron SEM of skeletal and dental tissues Eur Cell Mater 24 2012 154 160